| Literature DB >> 35338192 |
Eun Bin Cho1,2, Daegyeom Kim3, ByeongChang Jeong3,4, Jong Hwa Shin5,6, Yeon Hak Chung5,6, Sung Tae Kim7, Byoung Joon Kim5,6, Cheol E Han8,9, Ju-Hong Min10,11,12.
Abstract
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are two representative chronic inflammatory demyelinating disorders of the central nervous system. We aimed to determine and compare the alterations of white matter (WM) connectivity between MS, NMOSD, and healthy controls (HC). This study included 68 patients with relapsing-remitting MS, 50 with NMOSD, and 26 HC. A network-based statistics method was used to assess disrupted patterns in WM networks. Topological characteristics of the three groups were compared and their associations with clinical parameters were examined. WM network analysis indicated that the MS and NMOSD groups had lower total strength, clustering coefficient, global efficiency, and local efficiency and had longer characteristic path length than HC, but there were no differences between the MS and NMOSD groups. At the nodal level, the MS group had more brain regions with altered network topologies than did the NMOSD group when compared with the HC group. Network alterations were correlated with Expanded Disability Status Scale score and disease duration in both MS and NMOSD groups. Two distinct subnetworks that characterized the disease groups were also identified. When compared with NMOSD, the most discriminative connectivity changes in MS were located between the thalamus, hippocampus, parahippocampal gyrus, amygdala, fusiform gyrus, and inferior and superior temporal gyri. In conclusion, MS patients had greater network dysfunction compared to NMOSD and altered short connections within the thalamus and inferomedial temporal regions were relatively spared in NMOSD compared with MS.Entities:
Mesh:
Year: 2022 PMID: 35338192 PMCID: PMC8956623 DOI: 10.1038/s41598-022-09065-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographics and clinical characteristics of study subjects.
| MS (n = 68) | NMOSD (n = 50) | HC (n = 26) | ||
|---|---|---|---|---|
| Sex, | 51 (75.0) | 42 (84.0) | 21 (80.8) | 0.481a |
| Age, years, mean ± SD | 34.7 ± 8.7 | 44.4 ± 11.6 | 35.3 ± 11.3 | < 0.001b |
| Disease duration, years, median (IQR) | 3.9 (1.725–7.275) | 2.75 (1.175–12.075) | NA | 0.467 |
| AQP4-IgG positivity, | 0 (0) | 45 (90.0) | NA | < 0.001 |
| Attack numbers, median (IQR) | 2 (1–4) | 3 (2–5) | NA | 0.129 |
| NA | ||||
| Cerebral hemisphere | 68 (100) | 22 (44.0) | < 0.001 | |
| Brainstem/cerebellum | 44 (64.7) | 23 (46.0) | 0.043 | |
| Spinal cord | 52 (76.5) | 38 (76.0) | 0.953 | |
| Optic nerve | 27 (39.7) | 28 (56.0) | 0.080 | |
| EDSS, median (IQR) | 1 (0–2.0) | 2.5 (1.5–6.0) | NA | < 0.001 |
| Use of drugsd, | 57 (83.8)e | 45 (90.0)f | NA | 0.333 |
MS multiple sclerosis, NMOSD neuromyelitis optica spectrum disorder, HC healthy control, EDSS expanded disability status scale, IQR interquartile range, NA not applicable.
ap value from chi-squared test.
bp value from ANOVA, posthoc tests results: MS vs. NMOSD (p < 0.001), HC vs. NMOSD (p = 0.004), and MS vs. HC (p > 0.05).
cSymptomatic involvement.
dTaken at the time of brain MRI.
eInterferon β-1b (n = 24), interferon β-1a (n = 11), teriflunomide (n = 8), azathioprine (n = 5), fingolimod (n = 3), glatiramer acetate (n = 3), dimethyl fumarate (n = 2), mitoxantrone (n = 1).
fAzathioprine (n = 29), mycophenolate mofetil (n = 12), rituximab (n = 2), cyclosporine (n = 1), methotrexate (n = 1).
Comparison of global network topological measures between MS, NMOSD and HC groups.
| Network measures | MS | NMOSD | HC | Three group comparisona | MS < HCb,c | NMOSD < HCb,c | MS < NMOSDb,c |
|---|---|---|---|---|---|---|---|
| Total strength | 299.197 ± 33.021 | 298.906 ± 40.273 | 324.588 ± 26.187 | 0.005 | < 0.001 | 0.012 | 0.931 |
| Clustering coefficient | 0.187 ± 0.016 | 0.191 ± 0.016 | 0.202 ± 0.013 | < 0.001 | < 0.001 | 0.041 | 0.132 |
| Characteristic path length | 4.750 ± 0.462 | 4.769 ± 0.695 | 4.383 ± 0.254 | 0.005 | < 0.001 | 0.013 | 0.672 |
| Local efficiency | 0.340 ± 0.028 | 0.343 ± 0.028 | 0.370 ± 0.020 | < 0.001 | < 0.001 | 0.002 | 0.506 |
| Global efficiency | 0.237 ± 0.020 | 0.238 ± 0.023 | 0.256 ± 0.014 | < 0.001 | < 0.001 | 0.003 | 0.953 |
MS multiple sclerosis, NMOSD neuromyelitis optica spectrum disorder, HC healthy control; Data area expressed as mean ± standard deviation.
ap values from the permutation-based ANCOVA controlling for age and sex between three groups (MS, NMOSD, HC).
bA < B, decreased values in A relative to B.
cFDR adjusted p values of post-hoc tests based on the permutation based ANCOVA controlling for age and sex.
The associations between global network measures and clinical parameters (disease duration and EDSS) in the MS and NMOSD groups.
| Network topological measures | MS | NMOSD | ||||||
|---|---|---|---|---|---|---|---|---|
| Disease duration | EDSS | Disease duration | EDSS | |||||
| Beta | Beta | Beta | Beta | |||||
| Total strength | − 2.3647 | 0.0185 | − 3.6249 | 0.1360 | − 1.9158 | 0.0463 | − 6.4236 | 0.0013 |
| Clustering coefficient | − 0.0011 | 0.0143 | − 0.0020 | 0.0736 | − 0.0009 | 0.0102 | − 0.0030 | < 0.0001 |
| Characteristic path length | 0.0309 | 0.0243 | 0.0800 | 0.0144 | 0.0301 | 0.0719 | 0.1111 | 0.0013 |
| Local efficiency | − 0.0020 | 0.0159 | − 0.0044 | 0.0280 | − 0.0016 | 0.0143 | − 0.0051 | 0.0002 |
| Global efficiency | − 0.0014 | 0.0192 | − 0.0029 | 0.0463 | − 0.0013 | 0.0234 | − 0.0038 | 0.0010 |
MS multiple sclerosis, NMOSD neuromyelitis optica spectrum disorders, EDSS expanded disability status scale.
The post-hoc test result for the identified subnetworks through network-based statistics.
| Subnetwork | Edges | MS < HCa,b | NMOSD < HCa,b | MS < NMOSDa,b |
|---|---|---|---|---|
| 1 | Hippocampus_L-ParaHippocampal_L | 0.0120 | 0.3675 | 0.1476 |
| Hippocampus_L-Fusiform_L | 0.0016 | 0.4264 | 0.0016 | |
| Hippocampus_L-Temporal_Pole_Mid_L | 0.0003 | 0.0809 | 0.6019 | |
| Hippocampus_L-Temporal_Inf_L | 0.0003 | 0.0027 | 0.1291 | |
| ParaHippocampal_L-Fusiform_L | 0.0117 | 0.4330 | 0.0648 | |
| Amygdala_L-Fusiform_L | 0.0006 | 0.3211 | 0.0023 | |
| Amygdala_L-Temporal_Inf_L | 0.0006 | 0.1159 | 0.0960 | |
| Fusiform_L-Temporal_Inf_L | 0.0009 | 0.0944 | 0.0944 | |
| Lingual_L-Temporal_Inf_L | 0.0015 | 0.0156 | 0.5481 | |
| Angular_L-Temporal_Mid_L | 0.0042 | 0.0156 | 0.8146 | |
| Thalamus_L-Temporal_Inf_L | 0.0009 | 0.0943 | 0.1657 | |
| Temporal_Sup_L-Temporal_Inf_L | 0.0108 | 0.5087 | 0.0330 | |
| Temporal_Mid_L-Temporal_Inf_L | 0.0003 | 0.0036 | 0.3916 | |
| Angular_L-Temporal_Mid_L | 0.0042 | 0.0156 | 0.8146 | |
| Temporal_Pole_Sup_L-Temporal_Mid_L | 0.0132 | 0.0149 | 0.8908 | |
| Parietal_Sup_L-Precuneus_L | 0.0027 | 0.0248 | 0.8553 | |
| Parietal_Sup_L-Precuneus_R | 0.0060 | 0.1915 | 0.1915 | |
| Precuneus_L-Precuneus_R | 0.0045 | 0.0075 | 0.6966 | |
| Precuneus_R-Paracentral_Lobule_R | 0.0144 | 0.2193 | 0.0335 | |
| Cuneus_R-Precuneus_R | 0.0060 | 0.1610 | 0.3292 | |
| Occipital_Sup_R-Precuneus_L | 0.0015 | 0.0024 | 0.1714 | |
| Occipital_Sup_R-Precuneus_R | 0.0629 | 0.4413 | 0.0629 | |
| Calcarine_L-Cuneus_L | 0.0138 | 0.0360 | 0.6150 | |
| Calcarine_R-Occipital_Sup_L | 0.0003 | 0.0362 | 0.5915 | |
| Cuneus_L-Occipital_Sup_L | 0.0015 | 0.2552 | 0.1632 | |
| Cuneus_L-Occipital_Sup_R | 0.0183 | 0.0928 | 0.1210 | |
| Occipital_Sup_L-Occipital_Mid_L | 0.0030 | 0.1429 | 0.3463 | |
| Occipital_Mid_L-Fusiform_L | 0.0057 | 0.0121 | 0.9828 | |
| Occipital_Mid_L-Temporal_Inf_L | 0.0045 | 0.0060 | 0.7591 | |
| 2 | Hippocampus_R-ParaHippocampal_R | 0.0189 | 0.9795 | 0.0189 |
| Hippocampus_R-Fusiform_R | 0.0033 | 0.9492 | 0.0006 | |
| Hippocampus_R-Thalamus_R | 0.0021 | 0.0546 | 0.5244 | |
| ParaHippocampal_R-Fusiform_R | 0.0120 | 0.7685 | 0.0120 | |
| ParaHippocampal_R-Thalamus_R | 0.0243 | 0.9313 | 0.0440 |
MS multiple sclerosis, NMOSD neuromyelitis optica spectrum disorders, HC healthy controls, Temporal_Pole_Mid Temporal pole: middle temporal gyrus, Temporal_Inf Inferior temporal gyrus, Temporal_Mid Middle temporal gyrus, Temporal_Sup Superior temporal gyrus, Temporal_Pole_Sup Temporal pole: superior temporal gyrus, Parietal_Sup Superior parietal gyrus, Occipital_Sup Superior occipital gyrus, Occipital_Mid Middle occipital gyrus, R right; L left.
aA < B, decreased edges in A relative to B.
bFDR adjusted p values of post-hoc tests based on the permutation based ANCOVA controlling for age and sex.
Figure 1The two disrupted subnetworks in the multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) groups as identified through network-based statistics. Significantly different connections between (A) three groups (MS, NMOSD, healthy controls [HC]), (B) MS and HC, (C) NMOSD and HC, and (D) MS and NMOSD were displayed; each edge was disrupted in MS or NMOSD compared with HC and there were no edges with increased edge weights in NMOSD compared with MS. The left column displays the lateral view of the left hemisphere, the middle column displays the transverse views of both hemispheres, and the right column displays the lateral view of the right hemisphere. The blue and red circles are the brain regions of subnetworks 1 and 2, respectively. The orange lines are the edges that connect each region. HIP hippocampus, PHG parahippocampal gyrus, AMYG amygdala, CAL calcarine fissure, CUN cuneus, LING lingual gyrus, SOG superior occipital gyrus, MOG middle occipital gyrus, FFG fusiform gyrus, SPG superior parietal gyrus, ANG angular gyrus, PCUN precuneus, PCL paracentral lobule, THA thalamus, STG superior temporal gyrus, TPOsup temporal pole: superior temporal gyrus, MTG middle temporal gyrus, TPOmid temporal pole: middle temporal gyrus, ITG inferior temporal gyrus.